A Prospective Observational Registry of H.P. Acthar Gel for the Treatment of Multiple Sclerosis Relapse
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Mallinckrodt plc
- 22 Sep 2017 Planned End Date changed from 1 Mar 2018 to 1 Dec 2018.
- 22 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2018.
- 25 May 2017 Preliminary demographic data and safety results published in a Mallinckrodt plc media release.